The Levels of Serum C-Reactive Protein, Beta 2 Microglobulin, Ferritin, Lactate Dehydrogenase and Some Specific Proteins in Pati
![Shinji TSUKAMOTO | Medical Doctor | PhD | Nara Medical University, Kashihara-shi | Department of Orthopaedic Surgery Shinji TSUKAMOTO | Medical Doctor | PhD | Nara Medical University, Kashihara-shi | Department of Orthopaedic Surgery](https://www.researchgate.net/publication/353966284/figure/fig1/AS:1058023816577032@1629263943439/The-treatment-algorithm-for-giant-cell-tumor-of-bone-GCTB-giant-cell-tumor-of-bone_Q320.jpg)
Shinji TSUKAMOTO | Medical Doctor | PhD | Nara Medical University, Kashihara-shi | Department of Orthopaedic Surgery
![High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients - ScienceDirect High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419344333-gr4.jpg)
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients - ScienceDirect
![Shinji TSUKAMOTO | Medical Doctor | PhD | Nara Medical University, Kashihara-shi | Department of Orthopaedic Surgery Shinji TSUKAMOTO | Medical Doctor | PhD | Nara Medical University, Kashihara-shi | Department of Orthopaedic Surgery](https://www.researchgate.net/publication/353966284/figure/fig2/AS:1058023816564736@1629263943570/The-treatment-algorithm-for-desmoid-tumors-PFS-progression-free-survival_Q320.jpg)
Shinji TSUKAMOTO | Medical Doctor | PhD | Nara Medical University, Kashihara-shi | Department of Orthopaedic Surgery
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure2.gif)